StockWatch
·
USHA MARTIN LTD. · Q2 FY27 · THE VERDICT

Margins Defend, Volumes Await H2 Recovery

Operating margins held at 20%+, but H1 volumes came in flat — a quarter of steady execution masking an urgent half-year tension: the full-year 10–12% growth target now rests entirely on H2 pickup.

Q2 FY27 resultsUSHAMARTUSHA MARTIN LTD.19 Nov 2026 · 6 min read
H1 Revenue

₹2,021 Cr

+14.8% YoY; on track for 15% FY27 guidance

H1 EBITDA Margin

20.3%

vs 20% guidance; +220 bps YoY

H1 Volumes

101,000 MT

flat YoY; 10–12% FY27 growth target at risk

Q2 PAT

₹124.4 Cr

+13.3% YoY; -12.4% QoQ (UM Cables ₹11.6 Cr impact)

Usha Martin delivered what it promised on margins — 20.3% EBITDA in H1, defending the 20% guidance through a rising cost and demand environment. But margins alone don't make a quarter. The unfinished story is volumes: H1 came in flat at 101,000 MT despite a full-year 10–12% growth target. This isn't a reporting glitch. The Middle East headwind that management blamed for the slowdown (down 30% due to geopolitical disruption and 4–6× freight spikes) is now expected to ease in H2, but that recovery isn't yet proven. Capex guidance was also cut from ₹250–300 Cr to ₹200–250 Cr, signaling management's own caution on near-term demand.

The quarter in numbers

On the top line, Usha Martin is in line. Q2 revenue of ₹1,000 Cr represents 10.2% YoY growth and maintains the H1 run-rate of 14.8% YoY. At that pace, the ₹15% value-growth guidance for FY27 is achievable. At the operating line, the story is steady: OPM 20.2% in Q2 (matching H1's 20.3% EBITDA margin), well-defended despite input cost inflation and logistics pressures that forced some rope segments to absorb margin compression. Free cash flow in H1 reached ₹186 Cr off ₹413 Cr operating cash flow — a 101% EBITDA-to-OCF conversion, putting the company on track for the ₹100% cash-conversion guidance for FY27. Net cash stands at ₹415 Cr (after ₹77 Cr UM Cables divestment proceeds and dividends paid), leaving headroom for capex.

On PAT, the read is mixed. Consolidated PAT came in at ₹124.4 Cr (+13.3% YoY), but that headline carries a ₹11.6 Cr headwind from the UM Cables divestment (continuing ops would have delivered ₹136 Cr). More notably, the sequential print — ₹124.4 Cr in Q2 vs an implied ₹141.8 Cr in Q1 — shows a -12.4% QoQ compression. That's not explained away by mix or seasonal factors; it reflects the volume flatness and quarterly cost timing.

Management's key claims vs. what holds up

Q2 OPM 20.2%, margins maintained

Supported

Confirmed: 20.2% delivered; 20.3% H1 average; +70 bps YoY

Q2 PAT ₹136 Cr; 10% YoY growth

Overstated

Consolidated ₹124.4 Cr (₹11.6 Cr UM Cables gap). Continuing ops ~₹136 Cr, but UM divestment is real headwind.

Domestic wire ropes +14% YoY; wires up 21.7% volumes, +35% revenue

Supported

Supported: domestic ropes 12,700 MT in Q2 (+14% YoY); wires business strong across auto, springs, power transmission.

H1 volumes at 101,000 MT; FY27 target 10–12% growth

Contradicted

H1 volumes confirmed at 101,000 MT flat YoY. FY27 target now at risk; H2 must deliver substantial growth to hit guidance.

FY27 capex ₹200–250 Cr (prior ₹250–300 Cr)

Acknowledged

Capex range explicitly narrowed and lowered. Signals caution on demand and capital allocation discipline.

What changed on this call

Three material shifts from Q1 guidance: Capex range was tightened from ₹250–300 Cr to ₹200–250 Cr, signaling either lower capex intensity or management's own caution on near-term demand. Allocations remain unchanged (elevator rope, specialized ropes, plasticated LRPC, wire capacity), but the belt is tighter. Volume guidance for FY27 (10–12% growth) was no longer explicitly reaffirmed; instead, management pivoted to 'volume is a priority' and blamed geopolitical/logistics for H1 flatness, deferring full-year confidence to H2 recovery. This is material confidence erosion — in Q1, management had committed to that target; now it's conditional on H2 pickup. Margin guidance (20% minimum, 20–21% range) was maintained, and H1 delivery of 20.3% validates the hold, but the path was harder (mix shift to specialization, working capital optimization, pricing discipline in some segments).

On the structural front, the elevator rope expansion (6,000 MT/annum by Q1 FY28) remains on track, with 500 MT/month capacity commissioned in Ranchi. Management doubled down on confidence in demand (elevator market growing 20–25% annually, unable to meet current demand), signaling this is a supply-constrained market, not a demand risk. Plasticated LRPC (higher-margin variant of commodity black LRPC) has shipped its first unit to SE Asia and is under active negotiations on large projects; management expects 'significant order book' within 2–3 quarters. Thailand turnaround program launched with an 18-month horizon to uplift EBITDA margins from 6–7% (currently) to 14–15% (target). These are real catalysts, but they're Q1 FY28+ stories.

The bull-bear ledger
  • Margins at 20%+ despite inflation; H1 delivery confirms guidance

  • Domestic ropes +14%, wires +35% revenue — core segments firing

  • Cash generation strong: ₹186 Cr FCF in H1, ₹415 Cr net cash

  • Elevator rope 6K MT/annum by Q1 FY28; market growing 20–25% annually

  • H1 volumes flat (101K MT) vs 10–12% FY27 target — full-year growth now at risk

  • Q2 QoQ PAT down -12.4%; sequential weakness not explained

  • Middle East -30% YoY; logistics relief assumed in H2 but not yet proven

  • LRPC commoditized, down 17%; shift to plasticated depends on project wins

  • Capex guidance cut from ₹250–300 Cr to ₹200–250 Cr; signals caution

  • Thailand turnaround underway; 18-month horizon with execution risk

Risks, ranked by how much they should concern a holder

Volume guidance miss (H1 flat, FY27 10–12% now at risk)

High

If H2 doesn't deliver substantial growth, the full-year target becomes a miss. This is the core narrative investors were sold. Miss would hit stock multiple and credibility.

Geopolitical / logistics uncertainty (Red Sea, Middle East)

High

Middle East -30% headwind was material (₹300–400 Cr annual turnover at risk). Relief in H2 is assumed; if disruptions persist, volumes won't recover and capex ROI could suffer.

Capex underutilization (elevator rope demand doesn't materialize)

Medium

Elevator rope market is growing 20–25% annually, but macro downturn could weaken. If capex (₹200–250 Cr) doesn't get absorbed quickly, ROI suffers.

LRPC commoditization and margin erosion

Medium

Black LRPC is down 17% and commoditized; shift to plasticated depends on project wins. If plasticated doesn't scale, the segment remains a margin drag.

Thailand turnaround execution (6–7% margins currently vs 20% group)

Medium

18-month turnaround is long-dated and uncertain. If cost or mix initiatives stall, Thailand remains a drag on group EBITDA.

QoQ PAT compression signals sequential weakness

Low-Medium

Q2 PAT down -12.4% QoQ despite margin hold suggests cost/working capital timing or volume mix headwind. If structural, it weakens the narrative.

How the street is positioned: The stock is trading at ₹475, down 12.35% from its all-time high of ₹541.9, but positioned between the SMA200 (₹469.75, below) and SMA50 (₹488.9, above). RSI sits at 48.4 — neutral, neither overbought nor oversold. The 52-week range is ₹380–₹541.9; the current price represents a +25% move off the low, but a -12% drawdown from the ATH. This is a stock in consolidation, neither frothy nor deeply depressed. Ownership has been stable: FII at 15.11% (up 24 bps QoQ), DII at 17.07% (up 205 bps QoQ), promoter at 37.87% (down 19 bps QoQ). The DII accumulation is notable — suggests domestic institutions are building in the dip. Promoter trimming is marginal and not a red flag. The price action is consistent with the fundamental tension: margins OK (supports the stock), volume growth at risk (caps upside).

What to watch next
  • 1 · H2 FY27 volume recovery

    The make-or-break metric for FY27 guidance. H1 came in flat at 101K MT. To hit the 10–12% FY27 growth target, H2 volumes must grow substantially year-on-year. Management has deferred full-year confidence to H2 pickup, banking on Middle East relief and domestic strength continuing. This single metric will determine whether the full-year narrative holds.

  • 2 · Elevator rope capacity ramp and pricing validation

    6,000 MT/annum by Q1 FY28 is on track, but demand absorption and pricing are make-or-break. Management says the market can't be met and growth is 20–25% annually. Next quarter's orders, pricing, and utilization run-rate will validate (or undermine) that confidence.

  • 3 · Plasticated LRPC project wins and margin uplift

    First shipment accepted; active negotiations on large projects. Within 2–3 quarters, management expects 'significant order book.' If wins materialize and plasticated LRPC ramps to 2K–3K MT/annum at 25–30% EBITDA margins (vs 10–15% for black LRPC), the margin uplift could offset LRPC volume pressure and diversify the portfolio away from commodity.

Usha Martin is a story of steady operational execution masking an uncomfortable structural tension: the company is pivoting from commodity to specialization, and that pivot is happening at the worst time — when volume growth has stalled. Margins are holding (a real achievement in this environment), cash is strong (₹415 Cr net cash, 101% OCF conversion), and the elevator rope catalyst is high-conviction. But the full-year 10–12% volume growth target, once a confident commitment, is now contingent on H2 recovery that hasn't yet been proven. The street is properly positioned — the stock is not cheap, but it's not dear either. The DII accumulation suggests confidence in the structural story; FII is stable; promoter trimming is marginal.

The honest read: This is a quarter of steady, not exceptional, execution. Margins defended, cash generated, domestic segments firing — but H1 volumes flat and FY27 growth now at risk. The elevator rope story is real and will drive value, but it's a next-quarter catalyst, not a Q2 story. For now, the number to track is H2 FY27 organic volume growth — it needs to be substantial to validate the guidance. If it comes in, Usha Martin re-rates higher. If it doesn't, the valuation compression continues.

Informational and educational content only. Not investment advice.